Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the arimidex, tamoxifen, alone or in combination trial

Dowsett, M. et al. (2008) Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the arimidex, tamoxifen, alone or in combination trial. Journal of Clinical Oncology, 26(7), pp. 1059-1065.

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Mallon, Dr Elizabeth and Quinn, Dr Elizabeth
Authors: Dowsett, M., Allred, C., Knox, J., Quinn, E., Salter, J., Wale, C., Cuzick, J., Houghton, J., Williams, N., Mallon, E., Bishop, H., Ellis, I., Larsimont, D., Sasano, H., Carder, P., Cussac, A., Knox, F., Speirs, V., Forbes, J., and Buzdar, A.
College/School:College of Medical Veterinary and Life Sciences
Journal Name:Journal of Clinical Oncology

University Staff: Request a correction | Enlighten Editors: Update this record